SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-21-000128
Filing Date
2021-02-12
Accepted
2021-02-12 16:39:47
Documents
5
Period of Report
2021-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT f8k021121_8k.htm 8-K 23439
2 EXHIBIT 1.1 UNDERWRITING AGREEMENT f8k021121_ex1z1.htm EX-1.1 245447
3 EXHIBIT 5.1 LEGAL OPINION AND CONSENT f8k021121_ex5z1.htm EX-5.1 9294
4 EXHIBIT 99.1 PRESS RELEASE f8k021121_ex99z1.htm EX-99.1 11950
5 IMAGE f8k021121ex5z1_1.jpg GRAPHIC 33727
  Complete submission text file 0001078782-21-000128.txt   337267
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 21628553
SIC: 2835 In Vitro & In Vivo Diagnostic Substances